CJC-1295 and Ipamorelin are complementary peptides often paired in research for their synergistic interaction with the body’s growth hormone signaling pathways. Together, they are studied for their potential to support natural growth hormone release, which is associated in research settings with improved recovery, lean muscle support, fat metabolism, sleep quality, and overall vitality. Ipamorelin is known for its selective action and gentle profile, while CJC-1295 is valued for extending growth hormone signaling, making the combination popular in performance, recovery, and longevity-focused research.